List of Contents

Biophotonics Market Size, Share, and Trends 2024 to 2034

Biophotonics Market (By End-use: Tests and Components, Medical Therapeutics, Medical Diagnostics, Non-medical Application; By Technology: In-Vitro, In-Vivo; By Application: See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics sensing, Light therapy, Surface imaging, Biosensors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : July 2024
  • Report Code : 3879
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biophotonics Market 

5.1. COVID-19 Landscape: Biophotonics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biophotonics Market, By End-use

8.1. Biophotonics Market, by End-use, 2024-2034

8.1.1 Tests and Components

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Medical Therapeutics

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Medical Diagnostics

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Non-medical Application

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Biophotonics Market, By Technology

9.1. Biophotonics Market, by Technology, 2024-2034

9.1.1. In-Vitro

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. In-Vivo

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Biophotonics Market, By Application 

10.1. Biophotonics Market, by Application, 2024-2034

10.1.1. See-Through imaging

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Microscopy

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Inside Imaging

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Spectro Molecular

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Analytics sensing

10.1.5.1. Market Revenue and Forecast (2021-2034)

10.1.6. Light therapy

10.1.6.1. Market Revenue and Forecast (2021-2034)

10.1.7. Surface imaging

10.1.7.1. Market Revenue and Forecast (2021-2034)

10.1.8. Biosensors

10.1.8.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Biophotonics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by End-use (2021-2034)

11.1.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.3. Market Revenue and Forecast, by Application (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by End-use (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.4.3. Market Revenue and Forecast, by Application (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by End-use (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.1.5.3. Market Revenue and Forecast, by Application (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by End-use (2021-2034)

11.2.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.3. Market Revenue and Forecast, by Application (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by End-use (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.4.3. Market Revenue and Forecast, by Application (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by End-use (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.5.3. Market Revenue and Forecast, by Application (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by End-use (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.6.3. Market Revenue and Forecast, by Application (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by End-use (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.2.7.3. Market Revenue and Forecast, by Application (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by End-use (2021-2034)

11.3.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.3. Market Revenue and Forecast, by Application (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by End-use (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.4.3. Market Revenue and Forecast, by Application (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by End-use (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.5.3. Market Revenue and Forecast, by Application (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by End-use (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.6.3. Market Revenue and Forecast, by Application (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by End-use (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.3.7.3. Market Revenue and Forecast, by Application (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by End-use (2021-2034)

11.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.3. Market Revenue and Forecast, by Application (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by End-use (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.4.3. Market Revenue and Forecast, by Application (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by End-use (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.5.3. Market Revenue and Forecast, by Application (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by End-use (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.6.3. Market Revenue and Forecast, by Application (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by End-use (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Technology (2021-2034)

11.4.7.3. Market Revenue and Forecast, by Application (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by End-use (2021-2034)

11.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.3. Market Revenue and Forecast, by Application (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by End-use (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.4.3. Market Revenue and Forecast, by Application (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by End-use (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Technology (2021-2034)

11.5.5.3. Market Revenue and Forecast, by Application (2021-2034)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Hamamatsu Photonics K.K.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Olympus Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. PerkinElmer Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Becton, Dickinson and Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Carl Zeiss AG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Andor Technology Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Affymetrix, Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bruker Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Newport Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global biophotonics market size is expected to increase USD 226.18 billion by 2034 from USD 75.42 billion in 2023.

The global biophotonics market will register growth rate of 10.5% between 2024 and 2034.

The major players operating in the biophotonics market are Thermo Fisher Scientific Inc., Hamamatsu Photonics K.K., Olympus Corporation, PerkinElmer Inc., Becton, Dickinson and Company, Carl Zeiss AG, Andor Technology Ltd., Affymetrix, Inc., Bruker Corporation, Newport Corporation, Nikon Corporation, Coherent, Inc., Idex Corporation, Lumenis Ltd., Corning Incorporated, and Others.

The driving factors of the biophotonics market are the rising geriatric population and the demand for advanced medical technologies.

North America region will lead the global biophotonics market during the forecast period 2024 to 2034.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us